BDBM310908 6-methyl-4-(4-(4-methyl-3-oxopiperazine-1-carbonyl)phenyl)-1H-pyrrolo[2,3-c]pyridin-7(6H)-one::US10150767, Example 26
SMILES: CN1CCN(CC1=O)C(=O)c1ccc(cc1)-c1cn(C)c(=O)c2[nH]ccc12
InChI Key: InChIKey=MPKJQOHTLSMADE-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cat eye syndrome critical region protein 2 [424-538] (Homo sapiens (Human)) | BDBM310908![]() (6-methyl-4-(4-(4-methyl-3-oxopiperazine-1-carbonyl...) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair |